Numans Health Food Holdings Company Limited (HK:2530)
:2530
Want to see HK:2530 full AI Analyst Report?
2530 Stock Chart & Stats
HK$0.59
--
Market closed
HK$0.59
--
Day’s Range― - ―
52-Week RangeHK$0.45 - HK$0.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)43.20K
Market Cap
HK$800.00M
Enterprise ValueHK$206.75M
Total Cash (Recent Filing)HK$401.65M
Total Debt (Recent Filing)HK$3.77M
Price to Earnings (P/E)127.5
Beta0.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield8.95%
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,000,000,000
10 Day Avg. Volume61,600
30 Day Avg. Volume43,200
Financial Highlights & Ratios
PEG Ratio-1.11
Price to Book (P/B)1.12
Price to Sales (P/S)3.00
P/FCF Ratio11.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and substantial equity relative to assets provide durable financial flexibility. This conservative structure limits solvency risk, supports operational continuity through downturns, and preserves optionality for capex, buybacks or dividends without relying on external financing.
Solid Cash Generation And ConversionOperating cash flow and free cash flow remain positive and covered reported earnings by a wide margin. Strong cash conversion provides a reliable funding source for working capital, dividends and selective reinvestment, cushioning the business despite recent earnings volatility.
High Gross MarginsSustained high gross margins indicate enduring product-level pricing power or low direct costs. That structural margin advantage supports recovery in operating profits if SG&A is controlled and helps the company retain profitability resilience versus peers with thinner gross margins.
Bears Say
Sharp Revenue DeclineA 24% revenue drop signals structural demand or distribution setbacks that can persist beyond a single year. Reduced scale erodes fixed-cost absorption and market presence, making margin recovery and sustainable growth more difficult without clear signs of restored volume or new channels.
Collapsed Profitability And ReturnsProfitability and return on equity plunged, reflecting weakened earnings power. Persistently low margins and ROE impair the company's ability to generate shareholder returns, fund growth internally, and justify past capital allocation, raising questions about structural cost or demand shifts.
Declining Free Cash Flow TrendA steep FCF drop signals weakening underlying cash momentum even though conversion remains decent. Continued FCF erosion would limit reinvestment, reduce buffer for dividends or M&A, and constrain strategic flexibility unless operations stabilize and FCF generation recovers.
Numans Health Food Holdings Company Limited News
2530 FAQ
What was Numans Health Food Holdings Company Limited’s price range in the past 12 months?
Numans Health Food Holdings Company Limited lowest stock price was HK$0.45 and its highest was HK$0.80 in the past 12 months.
What is Numans Health Food Holdings Company Limited’s market cap?
Numans Health Food Holdings Company Limited’s market cap is HK$800.00M.
When is Numans Health Food Holdings Company Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Numans Health Food Holdings Company Limited’s earnings last quarter?
Currently, no data Available
Is Numans Health Food Holdings Company Limited overvalued?
According to Wall Street analysts Numans Health Food Holdings Company Limited’s price is currently Overvalued.
Does Numans Health Food Holdings Company Limited pay dividends?
Numans Health Food Holdings Company Limited pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of 8.95%. See more information on Numans Health Food Holdings Company Limited dividends here
What is Numans Health Food Holdings Company Limited’s EPS estimate?
Numans Health Food Holdings Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Numans Health Food Holdings Company Limited have?
Numans Health Food Holdings Company Limited has 1,000,000,000 shares outstanding.
What happened to Numans Health Food Holdings Company Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Numans Health Food Holdings Company Limited?
Currently, no hedge funds are holding shares in HK:2530
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Numans Health Food Holdings Company Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
1.08%
Trailing 12-Months
Asset Growth
29.32%
Trailing 12-Months
Company Description
Numans Health Food Holdings Company Limited
Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid (DHA), which supports brain and eye development in infants and children, and helps alleviate forgetfulness, anxiety, and postpartum depression in mothers. The company also offers probiotics, including solid drinks and lactic acid bacteria powders, to improve digestion and boost immunity for all ages. Other offerings include various vitamin and multi-nutrient products specifically formulated for pregnant women, infants, and children, as well as algal calcium and milk powders for diverse age groups. These products are distributed to consumers through both online platforms and traditional retail outlets. Established in Shanghai in 2002, Numans is a wholly-owned subsidiary of Far-East Fortune Management (China) Co., Ltd.
Technical Analysis
Besunyen Holdings Co. Ltd.
―
TS Wonders Holding Limited
―
Natural Food International Holding Ltd.
―
Vedan International (Holdings) Ltd.
―
China Starch Holdings Limited
―